A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, Walter J., Tschöpe, Carsten·2013·Journal of the American College of Cardiology

Cited by (1,005)

Items 201–300 of 1,005

  1. Quantitative Assessment of Coronary Microvascular Function
    Attila Fehér, Albert J. Sinusas · 2017 · Circulation Cardiovascular Imaging
  2. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers
    Filippos K. Triposkiadis, Andrew V. Xanthopoulos, John Parissis, Javed Butler, Dimitrios T. Farmakis · 2020 · Heart Failure Reviews
  3. Angiotensin 1–7 Ameliorates Diabetic Cardiomyopathy and Diastolic Dysfunction in db/db Mice by Reducing Lipotoxicity and Inflammation
    Jun Mori, Vaibhav B. Patel, Osama Abo Alrob, Ratnadeep Basu, Tariq Altamimi, Jessica DesAulniers, Cory S. Wagg, Zamaneh Kassiri, Gary D. Lopaschuk, Gavin Y. Oudit · 2014 · Circulation Heart Failure
  4. Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
    Nadezhda Glezeva, John Andrew Baugh · 2013 · Heart Failure Reviews
  5. The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
    Milton Packer · 2025 · Journal of the American College of Cardiology
  6. The Innate Immune System in Chronic Cardiomyopathy: A European Society of Cardiology (Esc) Scientific Statement from the Working Group on Myocardial Function of the ESC
    Stefan Frantz, Inês Falcão‐Pires, Jean‐Luc Balligand, Johann K Bauersachs, Dirk L. Brutsaert, Michele Ciccarelli, Dana K. Dawson, León J. De Windt, Mauro Giacca, Nazha Hamdani et al. · 2018 · European Journal of Heart Failure
  7. Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
    Laween Uthman, Antonius Baartscheer, Cees A. Schumacher, Jan W.T. Fiolet, Marius C. Kuschma, Markus Werner Hollmann, Ruben Coronel, Nina Claudia Weber, Coert Jozef Zuurbier · 2018 · Frontiers in Physiology
  8. Characterization of the Inflammatory-Metabolic Phenotype of Heart Failure with a Preserved Ejection Fraction: A Hypothesis to Explain Influence of Sex on the Evolution and Potential Treatment of the Disease
    Packer, Milton, Lam, Carolyn S.P., Lund, Lars H., Maurer, Mathew S., Borlaug, Barry A. · 2020 · European Journal of Heart Failure
  9. Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction
    Pandey, Ambarish, Shah, Sanjiv J., Butler, Javed, Kellogg, Dean L., Lewis, Gregory D., Forman, Daniel E., Mentz, Robert J., Borlaug, Barry A., Simon, Marc A., Chirinos, Julio A. et al. · 2021 · Journal of the American College of Cardiology
  10. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors
    Jennifer H. Jordan, Sujethra Vasu, Timothy M. Morgan, Ralph B. D’Agostino, Giselle C. Meléndez, Craig A. Hamilton, Andrew E. Arai, Songtao Liu, Chia‐Ying Liu, João A.C. Lima et al. · 2016 · Circulation Cardiovascular Imaging
  11. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry
    Jasper Tromp, Wan Ting Tay, Wouter Ouwerkerk, Tiew‐Hwa Katherine Teng, Jonathan Jiunn Liang Yap, Michael Ross MacDonald, Kirsten Leineweber, John J.V. McMurray, Michael R. Zile, Inder S. Anand et al. · 2018 · PLoS Medicine
  12. Soluble Guanylate Cyclase Stimulators and Activators
    Peter Sandner, Daniel P. Zimmer, G. Todd Milne, Markus Follmann, Adrian J. Hobbs, Johannes‐Peter Stasch · 2018 · Handbook of experimental pharmacology
  13. Sex Differences in Heart Failure
    Anuradha Lala, Upasana Tayal, CARINE E. HAMO, Quentin R. Youmans, Sana M. Al‐Khatib, Biykem Bozkurt, Melinda Baughman Davis, James L. Januzzi, Robert John Mentz, Andrew J. Sauer et al. · 2021 · Journal of Cardiac Failure
  14. Linking Heart Failure to Cancer
    Edoardo Bertero, Marco Canepa, Christoph Maack, Pietro Ameri · 2018 · Circulation
  15. Association of Cardiovascular Disease With Respiratory Disease
    Paul Carter, Jakub Lagan, Christien Fortune, Deepak L. Bhatt, Jørgen Vestbo, Robert McL. Niven, Nazia Chaudhuri, Erik B. Schelbert, Rahul Potluri, Chris Miller · 2019 · Journal of the American College of Cardiology
  16. Heart Failure With Preserved Ejection Fraction
    Francesco S. Loffredo, Andriana Nikolova, James R. Pancoast, Richard Theodore Lee · 2014 · Circulation Research
  17. Phenotypic Spectrum of Heart Failure with Preserved Ejection Fraction
    Sanjiv Jayendra Shah, Daniel H. Katz, Rahul C. Deo · 2014 · Heart Failure Clinics
  18. Pathophysiology and clinical evaluation of acute heart failure
    Robert John Mentz, Christopher M. O’Connor · 2015 · Nature Reviews Cardiology
  19. Endothelium-Dependent and Independent Coronary Microvascular Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction
    Jeong Hoon Yang, Masaru Obokata, Yogesh N.V. Reddy, Margaret M. Redfield, Amir Lerman, Barry A. Borlaug · 2019 · European Journal of Heart Failure
  20. Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes
    Jin Joo Park · 2021 · Diabetes & Metabolism Journal
  21. Heart failure with preserved ejection fraction
    CARINE E. HAMO, Colette DeJong, Nick Hartshorne‐Evans, Lars H. Lund, Sanjiv Jayendra Shah, Scott David Solomon, Carolyn S.P. Lam · 2024 · Nature Reviews Disease Primers
  22. Medical Therapy for Heart Failure Caused by Ischemic Heart Disease
    Islam Y. Elgendy, Dhruv Mahtta, Carl J. Pepine · 2019 · Circulation Research
  23. Abdominal ultrasound in the assessment of extent and activity of Crohn's disease: clinical significance and implication of bowel wall thickening.
    Giovanni Maconi, F. Parente, Simona Bollani, Bruno Mario Cesana, Gabriele Bianchi Porro · 1996 · PubMed
  24. Growth Differentiation Factor 15 in Heart Failure with Preserved vs. Reduced Ejection Fraction
    Michelle M. Y. Chan, Rajalakshmi Santhanakrishnan, Jenny P C Chong, Zhaojin Chen, Bee Choo Tai, Oi Wah Liew, Tze Pin Ng, Lieng Hsi Ling, David Sim, Kui Toh Gerard Leong et al. · 2015 · European Journal of Heart Failure
  25. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction
    Inder S. Anand, Brian Lee Claggett, Jiankang Liu, Amil M. Shah, Thomas S. Rector, Sanjiv Jayendra Shah, Akshay Suvas Desai, Eileen O’Meara, Jerome L. Fleg, Marc Alan Pfeffer et al. · 2017 · JACC Heart Failure
  26. Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects
    Jason R.B. Dyck, Samuel Tobias Sossalla, Nazha Hamdani, Ruben Coronel, Nina Claudia Weber, Peter E. Light, Coert Jozef Zuurbier · 2022 · Journal of Molecular and Cellular Cardiology
  27. The Right Heart in Heart Failure with Preserved Ejection Fraction: Insights from Cardiac Magnetic Resonance Imaging and Invasive Haemodynamics
    Stefan Aschauer, Andreas Anselm Kammerlander, Caroline Zotter‐Tufaro, Robin Ristl, Stefan Pfaffenberger, Alina F Bachmann, Franz Duca, Beatrice A. Marzluf, Diana Bonderman, Julia Mascherbauer · 2015 · European Journal of Heart Failure
  28. Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction
    Julia Mascherbauer, Beatrice A. Marzluf, Caroline Tufaro, Stefan Pfaffenberger, Alexandra Christine Graf, Paul Wexberg, Adelheid Panzenboeck, Johannes Jakowitsch, Christine Bangert, Daniela Laimer et al. · 2013 · Circulation Cardiovascular Imaging
  29. The microcirculation: a key player in obesity-associated cardiovascular disease
    Oana Sorop, T. Dylan Olver, Jens van de Wouw, ILKKA H. A. HEINONEN, Richard W. B. van Duin, Dirk Jan Duncker, Daphne Merkus · 2017 · Cardiovascular Research
  30. Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease
    Viviany R. Taqueti, Brendan M. Everett, Venkatesh Locharla Murthy, Mariya Gaber, Courtney R. Foster, Jon Mark Hainer, Ron Blankstein, Sharmila Dorbala, Marcelo F. Di Carli · 2014 · Circulation
  31. Inflammation in heart failure: pathophysiology and therapeutic strategies
    Jacinthe Boulet, Vikas S. Sridhar, Nadia Bouabdallaoui, Jean‐Claude Tardif, Michel White · 2024 · Inflammation Research
  32. Obesity-Related Heart Failure With a Preserved Ejection Fraction
    Packer, Milton, Kitzman, Dalane W. · 2018 · JACC: Heart Failure
  33. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction
    Camilla Hage, Erik Michaëlsson, Cecilia Marianne Linde, Erwan Donal, Jean‐Claude Daubert, Li‐Ming Gan, Lars H. Lund · 2017 · Circulation Cardiovascular Genetics
  34. Role of Oxidative Stress in Diabetic Cardiomyopathy
    Bart De Geest, Mudit Mishra · 2022 · Antioxidants
  35. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction
    Nannan Zhang, Bin Feng, Xuexing Ma, Kangyun Sun, Guidong Xu, Yafeng Zhou · 2019 · Cardiovascular Diabetology
  36. Heart failure and Alzheimer′s disease
    Pavla Čermáková, Maria Eriksdotter, Lars H. Lund, Bengt G. Winblad, Piotr Religa, Dorota Religa · 2014 · Journal of Internal Medicine
  37. Cellular senescence in cardiac diseases
    Ippei Shimizu, Tohru Minamino · 2019 · Journal of Cardiology
  38. The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
    Salvatore, Teresa, Pafundi, Pia Clara, Galiero, Raffaele, Albanese, Gaetana, Di Martino, Anna, Caturano, Alfredo, Vetrano, Erica, Rinaldi, Luca, Sasso, Ferdinando Carlo · 2021 · Frontiers in Medicine
  39. The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift
    Filippo Crea, C. Noel Bairey Merz, John Francis Beltrame, Juan Carlos Kaski, Hisao Ogawa, Peter Ong, Udo P Sechtem, Hiroaki Shimokawa, Paolo Guido Camici, On behalf of the Coronary Vasomotion Disorders International Study Group (COVADIS) · 2016 · European Heart Journal
  40. Microvascular complications in diabetes: A growing concern for cardiologists
    Angelo Avogaro, Gian Paolo Fadini · 2019 · International Journal of Cardiology
  41. Endothelial Dysfunction and Its Clinical Implications
    Pavel Poredoš, Aleksandra Visnovič-Poredoš, Igor D. Gregorič · 2021 · Angiology
  42. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets
    Marta Reina‐Couto, Patrícia Pereira‐Terra, Janete Quelhas‐Santos, Carolina Silva-Pereira, António Albino‐Teixeira, Teresa Sousa · 2021 · Frontiers in Physiology
  43. Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases
    Nakayama, Hiroyuki, Otsu, Kinya · 2018 · Biochemical Journal
  44. Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels
    Paolo Severino, Andrea D’Amato, Mariateresa Pucci, Fabio Infusino, Lucia Ilaria Birtolo, Marco Valerio Mariani, Carlo Lavalle, Viviana Maestrini, Massimo Mancone, Francesco Fedele · 2020 · International Journal of Molecular Sciences
  45. Heart Failure With Preserved Ejection Fraction
    Yogesh N.V. Reddy, Barry A. Borlaug · 2015 · Current Problems in Cardiology
  46. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis
    Selma H. Bouthoorn, Gideon Valstar, Aisha Gohar, Hester M. den Ruijter, Johannes B. Reitsma, Arno Wilhelmus Hoes, Frans Hendrik Rutten · 2018 · Diabetes and Vascular Disease Research
  47. Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
    Barry A. Borlaug, Vojtěch Melenovský, Katlyn E. Koepp · 2016 · Circulation Research
  48. Heart failure with preserved ejection fraction in the elderly: scope of the problem
    Bharathi Upadhya, George E. Taffet, Che Ping Cheng, Dalane W. Kitzman · 2015 · Journal of Molecular and Cellular Cardiology
  49. Echocardiography in shock management
    Anthony S. McLean · 2016 · Critical Care
  50. Innate immune memory after brain injury drives inflammatory cardiac dysfunction
    Alba Simats, Sijia Zhang, Denise Messerer, Faye Chong, Sude Beşkardeş, Aparna Sharma Chivukula, Jiayu Cao, Simon Besson‐Girard, Felipe A. Montellano, Caroline Morbach et al. · 2024 · Cell
  51. Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO
    Vincent F. M. Segers, Dirk L. Brutsaert, Gilles W. De Keulenaer · 2018 · Frontiers in Physiology
  52. Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction
    Obokata, Masaru, Reddy, Yogesh N.V., Melenovsky, Vojtech, Kane, Garvan C., Olson, Thomas P., Jarolim, Petr, Borlaug, Barry A. · 2018 · Journal of the American College of Cardiology
  53. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction
    Frank R. Heinzel, Felix Hohendanner, Ge Jin, Simon Sedej, Frank Edelmann · 2015 · Journal of Applied Physiology
  54. Exaggerated Inflammation and Monocytosis Associate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction: Evidence of M2 Macrophage Activation in Disease Pathogenesis
    Nadezhda Glezeva, Victor Voon, Chris J Watson, Stephen James Horgan, Kenneth McDonald, Mark T. Ledwidge, John Andrew Baugh · 2014 · Journal of Cardiac Failure
  55. Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models
    Withaar, Coenraad, Lam, Carolyn S P, Schiattarella, Gabriele G, de Boer, Rudolf A, Meems, Laura M G · 2021 · European Heart Journal
  56. Coenzyme Q10 and Heart Failure
    Abhinav Sharma, Gregg C. Fonarow, Javed Butler, Justin Adrian Ezekowitz, Gary Michael Felker · 2016 · Circulation Heart Failure
  57. Cardiac endothelium–myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction
    Shir Lynn Lim, Carolyn S.P. Lam, Vincent F. M. Segers, Dirk L. Brutsaert, Gilles W. De Keulenaer · 2015 · European Heart Journal
  58. Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction
    Antoine H. Chaanine, Lyle D. Joyce, John M. Stulak, Simon Maltais, David L. Joyce, Joseph A. Dearani, Katherine A. Klaus, K. Sreekumaran Nair, Roger J. Hajjar, Margaret M. Redfield · 2019 · Circulation Heart Failure
  59. Pulmonary Hypertension in HFpEF and HFrEF
    Marco Guazzi, Stefano Ghio, Yochai Adir · 2020 · Journal of the American College of Cardiology
  60. Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions
    Nicola Riccardo Pugliese, Pierpaolo Pellicori, Francesco Filidei, Nicolò De Biase, Pasquale Maffia, Tomasz Jan Guzik, Stefano Masi, Stefano Taddei, John G.F. Cleland · 2022 · Cardiovascular Research
  61. Heart Failure with Preserved Ejection Fraction: Uncertainties and Dilemmas
    Roberto Ferrari, Michael Böhm, John G.F. Cleland, Walter J. Paulus, Burkert Mathias Pieske, Claudio Rapezzi, Luigi Tavazzi · 2015 · European Journal of Heart Failure
  62. Heart failure with preserved ejection fraction: New approaches to diagnosis and management
    Bharathi Upadhya, Dalane W. Kitzman · 2019 · Clinical Cardiology
  63. Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction
    Kajenny Srivaratharajah, Thais A. Coutinho, Robert A. deKemp, Peter Xiaoping Liu, Haissam A. Haddad, Ellamae Stadnick, Ross A. Davies, Sharon Chih, Girish Dwivedi, Ann Guo et al. · 2016 · Circulation Heart Failure
  64. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
    Rebecca J. Woolley, Daan C H Ceelen, Wouter Ouwerkerk, Jasper Tromp, Sylwia Marta Figarska, Stefan D. Anker, Kenneth Dickstein, Gerasimos S Filippatos, Faiez M. Zannad, Marco Metra et al. · 2021 · European Journal of Heart Failure
  65. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction
    Kathryn Dryer, Mark M. Gajjar, Nikhil Narang, Margaret Lee, Jonathan Paul, Atman Prabodh Shah, Sandeep Nathan, Javed Butler, Charles J. Davidson, William Fuller Fearon et al. · 2018 · American Journal of Physiology-Heart and Circulatory Physiology
  66. Coronary blood flow in heart failure: cause, consequence and bystander
    Gerd Heusch · 2022 · Basic Research in Cardiology
  67. Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction
    Alogna, Alessio, Koepp, Katlyn E., Sabbah, Michael, Espindola Netto, Jair M., Jensen, Michael D., Kirkland, James L., Lam, Carolyn S.P., Obokata, Masaru, Petrie, Mark C., Ridker, Paul M. et al. · 2023 · JACC: Heart Failure
  68. Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
    Rohan Samson, Abhishek Jaiswal, Pierre Vladimir Ennezat, Mark M. Cassidy, Thierry H. Le Jemtel · 2016 · Journal of the American Heart Association
  69. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction
    Hilary M. DuBrock, Omar F. AbouEzzeddine, Margaret M. Redfield · 2018 · PLoS ONE
  70. Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning
    Åsa K. Hedman, Camilla Hage, Anil Kumar Sharma, M. Julia Brosnan, Leonard Buckbinder, Li‐Ming Gan, Sanjiv Jayendra Shah, Cecilia Marianne Linde, Erwan Donal, Jean‐Claude Daubert et al. · 2020 · Heart
  71. The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
    Anna Louise Beale, Joanne A. O’Donnell, Michael E. Nakai, Shane Nanayakkara, Donna Vizi, Kaye Carter, Eliza Dean, Rosilene V. Ribeiro, Stephanie R Yiallourou, Melinda Jane Carrington et al. · 2021 · Journal of the American Heart Association
  72. Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context
    Mpiko Ntsekhe, Jason V. Baker · 2022 · Circulation
  73. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study
    Reddy, Yogesh N.V., Lewis, Gregory D., Shah, Sanjiv J., Obokata, Masaru, Abou-Ezzedine, Omar F., Fudim, Marat, Sun, Jie-Lena, Chakraborty, Hrishikesh, McNulty, Steven, LeWinter, Martin M. et al. · 2019 · Mayo Clinic Proceedings
  74. Lung function and cardiovascular disease: A link
    Sérgio Henrique Rodolpho Ramalho, Amil M. Shah · 2020 · Trends in Cardiovascular Medicine
  75. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction
    Franz Duca, Andreas Anselm Kammerlander, Caroline Zotter‐Tufaro, Stefan Aschauer, Marianne L. Schwaiger, Beatrice A. Marzluf, Diana Bonderman, Julia Mascherbauer · 2016 · Circulation Cardiovascular Imaging
  76. Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4
    Javier Dı́ez, Arantxa González, Jason Ciril Kovacic · 2020 · Journal of the American College of Cardiology
  77. Patient selection in heart failure with preserved ejection fraction clinical trials
    Kelly, Jacob P., Mentz, Robert J., Mebazaa, Alexandre, Voors, Adriaan A., Butler, Javed, Roessig, Lothar, Fiuzat, Mona, Zannad, Faiez, Pitt, Bertram, O’Connor, Christopher M. et al. · 2015 · Journal of the American College of Cardiology
  78. Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities
    Ilona Cuijpers, Steven J. Simmonds, Marc van Bilsen, E. Czarnowska, Arantxa González, Stephane R B Heymans, Annika-Ricarda Kuhn, Paul G.H. Mulder, Anna Ratajska, Elizabeth A. V. Jones et al. · 2020 · Basic Research in Cardiology
  79. Cardiac metabolism in HFpEF: from fuel to signalling
    Federico Capone, Cristian Sotomayor-Flores, David Bode, Rongling Wang, Daniele Rodolico, Stefano Strocchi, Gabriele G. Schiattarella · 2022 · Cardiovascular Research
  80. The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
    Stephen John Greene, Mihai Gheorghiade, Barry A. Borlaug, Burkert Mathias Pieske, Muthiah Vaduganathan, John C. Jr Burnett, Lothar Roessig, Johannes‐Peter Stasch, Scott David Solomon, Walter J. Paulus et al. · 2013 · Journal of the American Heart Association
  81. From Left Ventricular Hypertrophy to Dysfunction and Failure
    Davide Lazzeroni, Ornella E. Rimoldi, Paolo Guido Camici · 2016 · Circulation Journal
  82. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction
    David M. Kaye, Gerd P Hasenfuss, Petr Neužil, Martijn C. Post, Robert Neil Doughty, Jean‐Noël Trochu, Adam Kołodziej, Ralf Westenfeld, Martin Pěnička, Mark Rosenberg et al. · 2016 · Circulation Heart Failure
  83. Declining Lung Function and Cardiovascular Risk
    Odílson Marcos Silvestre, Wilson Nadruz, Gabriela Querejeta Roca, Brian Lee Claggett, Scott David Solomon, Maria C. Mirabelli, Stephanie J. London, Laura R. Loehr, Amil M. Shah · 2018 · Journal of the American College of Cardiology
  84. SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?
    Steffen Pabel, Nazha Hamdani, Mark Luedde, Samuel Tobias Sossalla · 2021 · Current Heart Failure Reports
  85. Rationale and Design of The SOluble guanylate Cyclase StimulatoR in HeArT FailurE Studies (SOCRATES)
    Burkert Mathias Pieske, Javed Butler, Gerasimos S Filippatos, Carolyn S.P. Lam, Aldo Pietro Maggioni, Piotr P. Ponikowski, Sanjiv Jayendra Shah, Scott David Solomon, Elisabeth Kraigher‐Krainer, Eliana Sueco Tibana Samano et al. · 2014 · European Journal of Heart Failure
  86. Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance
    Sun Danan, Jin Wang, Sam Toan, David Muid, Ruibin Li, Xing Chang, Hao Zhou · 2022 · Angiogenesis
  87. Waist-To-Hip Ratio and Mortality in Heart Failure
    Koen W. Streng, Adriaan A. Voors, Hans L. Hillege, Stefan D. Anker, John G.F. Cleland, Kenneth Dickstein, Gerasimos S Filippatos, Marco Metra, Leong L. Ng, Piotr P. Ponikowski et al. · 2018 · European Journal of Heart Failure
  88. Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
    Domenico D’Amario, Stefano Migliaro, Josip A. Borovac, Attilio Restivo, Rocco Vergallo, Mattía Galli, Antonio Maria Leone, Rocco Antonio Montone, Giampaolo Niccoli, Nadia Aspromonte et al. · 2019 · Frontiers in Physiology
  89. Epidemiology and pathogenesis of heart failure with preserved ejection fraction
    Nandini Nair · 2020 · Reviews in Cardiovascular Medicine
  90. Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases
    Kai‐Fan Tsai, Yung‐Lung Chen, Terry Ting‐Yu Chiou, Tian‐Huei Chu, Lung‐Chih Li, Hwee‐Yeong Ng, Wen‐Chin Lee, Chien‐Te Lee · 2021 · Antioxidants
  91. Cellular senescence links aging and diabetes in cardiovascular disease
    Shakeri, Hadis, Lemmens, Katrien, Gevaert, Andreas B., De Meyer, Guido R. Y., Segers, Vincent F. M. · 2018 · American Journal of Physiology-Heart and Circulatory Physiology
  92. Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
    Axel Radlach Pries, Bettina Reglin · 2016 · European Heart Journal
  93. Predictors and Outcomes of Heart Failure with Mid-Range Ejection Fraction
    Vijeta Bhambhani, Jorge R. Kizer, João A.C. Lima, Pim van der Harst, Hossein Bahrami, Matthew Gregory Nayor, Christopher R. de Filippi, Danielle M. Enserro, Michael Joseph Blaha, Mary Cushman et al. · 2017 · European Journal of Heart Failure
  94. Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology
    Andreas B. Gevaert, Jente R. A. Boen, Vincent F. M. Segers, Emeline M. Van Craenenbroeck · 2019 · Frontiers in Physiology
  95. Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction
    Thomas M. Gorter, Gijs van Woerden, Michiel Rienstra, Michael G. Dickinson, Yoran M. Hummel, Adriaan A. Voors, Elke S. Hoendermis, Dirk Jan van Veldhuisen · 2020 · JACC Heart Failure
  96. Association Between Cardiovascular vs. Non-Cardiovascular Co-Morbidities and Outcomes in Heart Failure with Preserved Ejection Fraction
    Lars H. Lund, Erwan Donal, Emmanuel Oger, Camilla Hage, Hans Persson, Ida Haugen Löfman, Pierre‐Vladimir Ennezat, Catherine Sportouch, Élodie Drouet, Jean‐Claude Daubert et al. · 2014 · European Journal of Heart Failure
  97. Regional Adiposity and Heart Failure with Preserved Ejection Fraction
    Vishal N. Rao, Marat Fudim, Robert John Mentz, Erin D. Michos, Gary Michael Felker · 2020 · European Journal of Heart Failure
  98. Natriuretic Peptides, Heart, and Adipose Tissue: New Findings and Future Developments for Diabetes Research
    Gabriella Gruden, Andrea Landi, Graziella Bruno · 2014 · Diabetes Care
  99. Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction
    James E. Udelson, Gregory D. Lewis, Sanjiv Jayendra Shah, Michael R. Zile, Margaret M. Redfield, John C. Jr Burnett, John D. Parker, Jelena P. Seferović, Phebe J. Wilson, Robert S. Mittleman et al. · 2020 · JAMA
  100. Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
    Michael Frisk, Christopher Le, Xin Ming Shen, Åsmund Treu Røe, Yufeng Hou, Ornella Manfra, Gustavo José Justo da Silva, Isabelle van Hout, Einar Sjaastad Nordén, Jan Magnus Aronsen et al. · 2021 · Journal of the American College of Cardiology